RE:RE:RE:RE:RE:Share Price (Unbiased Opionion)IF all products are successful you could be right with your share prices. But be careful. We have only safety data for RCS and RCT. There are no before and after pics of RCS which for example don’t show reducing in skin aging with the products. We know that autologous cell therapy are safe.
but it is another question about the efficacy about RCS and RCT. Whether this products are competitive.
i don’t think that replicel will tell about a new partner shortly in an update because in lees recent post there was no hint on that. Also there could be some issues with the dermal injector. In my opinion the post of Lee was very passive. I can’t read anything heavy for 2020 coming. Maybe another research year without action...